1Orazi A, Germing U. The myelodysplastic/myeloprolifera- tire neoplasms:myeloproliferative diseases with dysplastic features [ J ]. Leukemia, 2008,22 (7) : 1308-1319.
2Oki Y,Jelinek J,Shen L,et al. Introduction of hypomethy- lation and molecular response after decitabine therapy in patient with chronic myelomonocytic leukemia[J].Blood, 2008,111(4) :2382-2384.
3Aribi A,Borthakur G,Ravandi F,et al. Activity of decitabine in the treatment of patients with chronic myelomonocytic leukemia[J].Cancer,2007,109(4) :713- 717.
